Simplex Trading, LLC Vaccinex, Inc. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$0.34 - $0.48 $20,134 - $28,425	-59,219 Reduced 99.43%	340 $0
Q1 2023 Apr 27, 2023	SELL	$0.39 - $0.65 $2,189 - $3,649	-5,615 Reduced 8.62%	59,559 $23,000
Q4 2022 Feb 02, 2023	SELL	$0.44 - $131.17 $602 - $179,702	-1,370 Reduced 2.06%	65,174 $41,000
Q3 2022 Nov 04, 2022	BUY	$0.48 - $109.22 $10,510 - $2.39 Million	21,896 Added 49.04%	66,544 $32,000
Q2 2022 Aug 03, 2022	BUY	$1.05 - $1.39 $46,880 - $62,060	44,648 New	44,648 $48,000
Q1 2022 May 02, 2022	SELL	$0.92 - $1.94 $5,202 - $10,970	-5,655 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$1.04 - $2.12 $3,463 - $7,059	3,330 Added 143.23%	5,655 $5,000
Q2 2021 Aug 12, 2021	BUY	$2.01 - $3.0 $4,673 - $6,975	2,325 New	2,325 $6,000
Q1 2021 Apr 26, 2021	SELL	$2.09 - $5.11 $2,564 - $6,269	-1,227 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$1.66 - $2.35 $28,822 - $40,803	-17,363 Reduced 93.4%	1,227 $2,000
Q3 2020 Oct 14, 2020	BUY	$1.75 - $8.19 $32,532 - $152,252	18,590 New	18,590 $33,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $109M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.